Financial Performance - The company's operating revenue for the first half of 2023 was approximately ¥710.49 million, a decrease of 30.17% compared to ¥1,017.46 million in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2023 was approximately ¥17.37 million, down 76.61% from ¥74.25 million in the previous year[18]. - The basic earnings per share for the first half of 2023 was ¥0.11, a decline of 76.09% compared to ¥0.46 in the same period last year[19]. - The net cash flow from operating activities was negative at approximately -¥70.47 million, a significant decrease from ¥14.85 million in the previous year, representing a decline of 574.71%[18]. - The total assets at the end of the reporting period were approximately ¥2.66 billion, a slight decrease of 0.40% from ¥2.67 billion at the end of the previous year[19]. - The net assets attributable to shareholders increased by 1.41% to approximately ¥1.62 billion from ¥1.60 billion at the end of the previous year[19]. - The weighted average return on net assets for the first half of 2023 was 1.08%, down from 5.13% in the same period last year, indicating a decline of 4.05%[19]. - The company reported a revenue of ¥710,486,957.94 for the current period, a decrease of 30.17% compared to ¥1,017,464,989.35 in the previous year[36]. - The operating costs decreased by 27.79% to ¥614,427,337.30 from ¥850,858,874.28 year-on-year[36]. - The company reported a net profit of 1,883.89 million RMB for the subsidiary Jiangsu Fengshan Biochemical Technology, significantly impacting the consolidated profit[48]. Investments and Projects - The company established a subsidiary, Jiangsu Fengshan Quannuo New Energy Technology Co., Ltd., to invest in a battery electrolyte project with a planned annual production capacity of 100,000 tons, with the first phase of 50,000 tons nearing completion[30]. - The company is developing a new material production base with an annual capacity of 130,000 tons of para-chlorotoluene, in collaboration with the Yichang High-tech Zone Management Committee[30]. - The company has initiated a project to produce 3,000 tons of green grass herbicide, which has completed trial production and is now in normal production[31]. - The company has established two subsidiaries in 2022 to expand into high-end fine chemical materials and electronic chemical products, with ongoing construction projects[25]. - The company has invested in advanced environmental protection facilities, achieving significant reductions in waste emissions and earning recognition as a leading environmentally friendly enterprise[26]. Research and Development - The company has established several research and development platforms, including a provincial technology center, to enhance its innovation capabilities[28]. - The company is committed to enhancing R&D investment to achieve product differentiation and improve competitiveness[50]. - Investment in R&D increased by 40% in 2023, focusing on innovative technologies to enhance product offerings[57]. - The company reported a significant increase in research and development expenses, totaling CNY 21,723,160.83 for the first half of 2023[145]. Environmental Initiatives - The company has upgraded its wastewater treatment facilities, increasing processing capacity to 4800 m³/d, improving overall efficiency[64]. - The company has implemented real-time monitoring systems for wastewater discharge, ensuring compliance with environmental standards[64]. - The company has constructed a rotary kiln with a daily processing capacity of 25 tons for hazardous waste, and a 36t/d waste salt incineration furnace, effectively converting hazardous waste into industrial salt that meets national standards[66]. - The company has received environmental impact assessment approvals for multiple projects, including a production line with an annual capacity of 1,000 tons of a specific pesticide and 20,000 tons of pesticide formulations[67]. - The company has been recognized as an "Advanced Environmental Protection Enterprise" in Jiangsu Province, reflecting its commitment to environmental responsibility[72]. Market Expansion and Strategy - The company is expanding its market presence in Southeast Asia, targeting a 20% market share by the end of 2024[57]. - The company plans to enhance its capital operations in 2023 by leveraging its public financing platform and exploring new business development models through equity participation and acquisitions[34]. - The company is considering strategic acquisitions to bolster its market position, with a budget of up to 500 million RMB allocated for potential deals[75]. - A new marketing strategy has been implemented, focusing on digital channels, which is expected to increase customer engagement by 30%[76]. Financial Stability and Shareholder Commitments - The company has maintained a clean record regarding compliance and has not faced any penalties or corrective actions during the reporting period[94]. - The company commits to adhering to regulations regarding shareholder shareholding and changes, ensuring compliance with relevant laws and rules[84]. - Shareholder commitments include a promise to maintain dividend payouts, with an expected total of 100 million RMB in dividends for the fiscal year[78]. - The company has a stable and sufficient cash arrangement to meet future obligations related to convertible bonds[131]. Risks and Challenges - The company faces risks related to raw material supply and price fluctuations, which could impact production and operational costs[50]. - The macroeconomic environment poses risks, with potential impacts on demand and competition in the fine chemical industry[50]. - Export business is subject to strict international trade regulations, which may affect sales and operational performance[51]. Compliance and Governance - The company has not reported any changes in accounting policies or prior period error corrections for the current period[173]. - The company’s financial statements are prepared in accordance with the enterprise accounting standards, ensuring a true and complete reflection of its financial status[191]. - The company has a continuous operating assumption, indicating no significant factors affecting its ability to continue operations within the next 12 months[189].

江苏丰山集团股份有限公司 关于举办2023年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 证券代码：603810 | 证券简称：丰山集团 公告编号：2023-073 | | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | 重要内容提示： 一、说明会类型 江苏丰山集团股份有限公司（以下简称"公司"）已于 2023 年 8 月 31 日在 上海证券交易所网站（www.sse.com.cn）披露了《2023 年半年度报告全文》及《2023 年半年度报告摘要》。为便于广大投资者更加全面深入地了解公司经营业绩、发 会议召开时间：2023 年 09 月 12 日（星期二）10:00-11:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 会议问题征集： 投 资 者 可 于 2023 年 09 月 12 日 前 访 问 网 址 https://eseb.cn/17zmRBerPr2 或使用微信扫描下方小程序码进行会前提 问，公司将通过本 ...

会议召开时间：2023 年 05 月 15 日（星期一）10:00-11:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 会议问题征集： 投 资 者 可 于 2023 年 05 月 15 日 前 访 问 网 址 https://eseb.cn/14qBE8vPv2M 或使用微信扫描下方小程序码进行会前提 问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普遍 关注的问题进行回答。 （www.ir-online.cn）举办江苏丰山集团股份有限公司 2022 年年度业绩说明会， 与投资者进行沟通和交流，广泛听取投资者的意见和建议。 二、说明会召开的时间、地点和方式 | 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2023-044 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于举办2022年年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ...

Financial Performance - The company's operating revenue for 2022 was CNY 1,709,170,519, representing a 12.59% increase compared to CNY 1,518,111,081 in 2021[20] - The net profit attributable to shareholders for 2022 was CNY 99,229,330.76, a decrease of 13.51% from CNY 114,725,344.99 in 2021[20] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 97,157,650.60, down 2.48% from CNY 99,624,503.09 in 2021[20] - Basic earnings per share decreased by 13.89% to CNY 0.62 in 2022 from CNY 0.72 in 2021[21] - Diluted earnings per share fell by 15.28% to CNY 0.61 in 2022 compared to CNY 0.72 in 2021[21] - Operating profit decreased by 23.94% to CNY 10,174,820, down from CNY 13,377,560 in the previous year[49] - The company's gross profit margin decreased by 3.4% due to a 17.35% increase in main business costs, which reached CNY 1,424,263,004[51] Cash Flow and Assets - The net cash flow from operating activities increased significantly to CNY 185,450,042.47, a 210.33% rise from CNY 59,758,888.25 in 2021[20] - The total assets of the company at the end of 2022 were CNY 2,667,197,386.94, reflecting a 33.85% increase from CNY 1,992,675,036.08 at the end of 2021[20] - The net assets attributable to shareholders increased to CNY 1,599,453,072.35, a 12.58% rise from CNY 1,420,679,028.35 in 2021[20] - The company's total financial assets increased from CNY 311.56 million at the beginning of the year to CNY 371.90 million by year-end, reflecting a change of CNY 60.34 million[29] - The company's cash and cash equivalents at the end of the period were approximately ¥705.04 million, a 93.32% increase from the previous year[67] Investments and Subsidiaries - The company established Jiangsu Fengshan Quannuo New Energy Technology Co., Ltd. in August 2022, planning to invest in a project with an annual production capacity of 100,000 tons of battery electrolyte[31] - In September 2022, the company set up Hubei Fengshan New Materials Co., Ltd. to develop high-end fine chemical materials, with a planned production capacity of 130,000 tons of para-chlorotoluene[31] - The company has established a wholly-owned subsidiary, Jiangsu Fengshan Biochemical Technology Co., Ltd., to strengthen its pesticide sector and enhance operational efficiency[32] - The company has established three new wholly-owned subsidiaries in 2022, expanding its operational scope and market presence[60] - The company holds 100% equity in Hubei Fengshan and Fengshan Biochemical, indicating a strategic focus on full ownership in new ventures[100] Research and Development - The company has established a comprehensive R&D mechanism, focusing on high-efficiency, low-toxicity, and environmentally friendly pesticide raw materials and intermediates[41] - The company’s research and development expenses increased by 12.07% to CNY 49,456,459[50] - The company has established strong R&D capabilities, with 20 authorized invention patents and 2 utility model patents as of December 31, 2022, indicating robust innovation potential[46] - The company is committed to developing high-end fine chemical products, including chlorinated and fluorinated chemicals, to enhance product competitiveness[120] Market Trends and Competition - The lithium-ion electrolyte market is expected to face intensified competition in 2023, with companies possessing cost and technological advantages likely to stand out[39] - The agricultural sector is expected to see a rise in pesticide production revenue from 228.06 billion to over 250 billion by 2025, indicating growth potential in the industry[74] - The agricultural chemical industry in China is undergoing consolidation, with government policies promoting mergers and acquisitions to increase industry concentration and competitiveness[114] - The electrolyte industry is shifting from capacity competition to R&D innovation competition, requiring manufacturers to develop new functional electrolyte solutions[119] Environmental Management - The company has made significant progress in environmental management, optimizing wastewater treatment processes to achieve high standards and low emissions[34] - The company has received multiple honors for its environmental efforts, including recognition as an advanced enterprise in environmental protection in Jiangsu Province[192] - The company has invested in pollution control facilities, enhancing the efficiency of "three wastes" treatment and reducing emissions[183] - The company has implemented a hazardous waste incineration system with a daily processing capacity of 25 tons, along with a 36 tons/day waste salt incinerator and a 60 tons/day liquid incinerator[186] Governance and Management - The company has established a governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and coordinated operations[132] - The board of directors comprises 9 members, including 3 independent directors, and has established specialized committees to provide professional opinions for decision-making[134] - The company has implemented a comprehensive investor relations management system, conducting multiple online performance briefings to enhance communication with investors[136] - The company plans to continue enhancing its governance structure and investor relations management to protect shareholders' rights and improve transparency[136] Future Outlook - The company provided a future outlook, projecting a revenue growth of 20% for the next fiscal year[146] - The company plans to accelerate the construction and implementation of three major industrial sectors in 2023, ensuring timely completion and operation of projects through synchronized recruitment and market development[123] - The company aims to enhance its core competitiveness in the high-end fine chemical industry, focusing on expanding raw materials, strengthening formulations, and refining new business areas[121]

Financial Performance - The company's operating revenue for Q1 2023 was ¥395,516,977.68, representing a decrease of 10.40% compared to the same period last year[4]. - The net profit attributable to shareholders was ¥10,385,354.62, down 65.99% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥5,053,350.10, a decline of 80.98% compared to the previous year[4]. - The basic earnings per share for the period was ¥0.06, reflecting a decrease of 68.42% year-on-year[4]. - Total operating revenue for Q1 2023 was ¥395,516,977.68, a decrease of 10.4% compared to ¥441,406,976.76 in Q1 2022[18]. - Net profit for Q1 2023 was ¥10,106,438.02, a decline of 66.9% from ¥30,534,902.58 in Q1 2022[19]. - Earnings per share for Q1 2023 were ¥0.06, compared to ¥0.19 in Q1 2022[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,734,177,151.27, an increase of 2.51% from the end of the previous year[5]. - Total assets increased to ¥2,734,177,151.27 in Q1 2023 from ¥2,667,197,386.94 in Q1 2022, reflecting a growth of 2.5%[16]. - Total liabilities rose to ¥1,104,516,111.41 in Q1 2023, up from ¥1,067,938,797.83 in Q1 2022, indicating an increase of 3.4%[16]. - The total assets of the company as of January 1, 2023, were 2,669,022,709.13 RMB, reflecting an increase from 2,667,197,386.94 RMB at the end of 2022[27]. - The company's total liabilities remained stable at 622,194,355.82 RMB for current liabilities as of January 1, 2023[28]. Cash Flow - The cash flow from operating activities was negative at -¥34,337,868.16, indicating a significant cash outflow[4]. - In Q1 2023, the company reported a net cash flow from operating activities of -34,337,868.16 RMB, an improvement from -117,559,973.13 RMB in Q1 2022[23]. - Total cash inflow from investment activities was 716,177,893.67 RMB, significantly higher than 198,248,341.42 RMB in the same period last year, resulting in a net cash flow from investment activities of 142,059,333.18 RMB[24]. - The company experienced a net increase in cash and cash equivalents of 102,272,809.30 RMB in Q1 2023, contrasting with a decrease of -95,472,615.50 RMB in Q1 2022[24]. Equity and Shareholder Information - The equity attributable to shareholders increased by 1.92% to ¥1,630,134,439.70 compared to the end of the previous year[5]. - The top shareholder, Yin Fengshan, holds 41.72% of the shares, indicating a strong control over the company[10]. - Total equity attributable to shareholders reached ¥1,599.45 million, reflecting a minor decrease of ¥70.49 thousand compared to the last report[29]. - The total equity, including minority interests, was reported at ¥1,599.26 million, a decrease of ¥70.49 thousand[29]. Operational Changes - The company reported a decrease in trading financial assets, which fell to CNY 100,464,126.73 from CNY 260,440,869.56, a decline of about 61.4%[14]. - The company experienced a 53.01% increase in accounts receivable, attributed to sales payments still within the credit period[7]. - The company’s profit margin was impacted by a decline in pesticide product prices and overall market conditions, leading to a 54.25% decrease in total profit[8]. - The company has announced several significant announcements regarding stock repurchase and fundraising projects during the reporting period[11]. - The company is actively engaging in market expansion and new product development as part of its strategic initiatives[11]. Research and Development - The company reported a decrease in research and development expenses to ¥8,469,002.33 in Q1 2023 from ¥12,316,781.49 in Q1 2022, a reduction of 31.5%[19]. Accounting Standards - The company has adopted new accounting standards effective January 1, 2023, which may impact financial reporting[25].

2022 年第三季度报告 证券代码：603810 证券简称：丰山集团 江苏丰山集团股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 | 年初至报告期末 | 年初至报告期 | | --- | --- | --- | --- | --- | | | | 比上年同 | | 末比上年同期 | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 366,145,145.38 | 19.03 | 1,383,610,134. ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥1,017,464,989.35, representing a 19.73% increase compared to ¥849,812,969.21 in the same period last year[20]. - The net profit attributable to shareholders decreased by 10.39% to ¥74,254,972.12 from ¥82,861,185.19 in the previous year[20]. - Basic earnings per share decreased by 11.54% to ¥0.46 from ¥0.52 in the same period last year[21]. - The weighted average return on equity decreased by 0.95 percentage points to 5.13% from 6.08% in the previous year[21]. - The company achieved operating revenue of RMB 1,017,464,989.35, representing a year-on-year growth of 19.73%[34]. - The net profit attributable to the parent company was RMB 74,255,000, a decrease of 10.39% compared to the previous year[34]. - The company reported a net profit of CNY 187.42 from Jiangsu Fengshan Agricultural Chemical Co., with total assets of CNY 22,379.12 million[52]. - The company reported a net profit of 58,095,912.00, indicating a stable performance[173]. - The total comprehensive income for the first half of 2022 was 77,061,128.4 RMB[181]. Cash Flow and Liquidity - The net cash flow from operating activities improved significantly, reaching ¥14,845,082.42, compared to a negative cash flow of ¥142,545,869.22 in the same period last year, marking a 110.41% increase[20]. - The company reported a cash inflow from investment activities of RMB 169,025,787.55 in the first half of 2022, compared to RMB 300,459,238.63 in the first half of 2021[157]. - The company's cash and cash equivalents at the end of the period were CNY 305,725,583.30, compared to CNY 204,992,637.72 at the end of the first half of 2021, reflecting an increase of approximately 49%[154]. - The company received CNY 59,106,782.76 in tax refunds, significantly higher than CNY 15,122,605.07 in the previous year, marking an increase of about 290%[152]. - Cash inflow from operating activities totaled RMB 679,431,148.17 in the first half of 2022, compared to RMB 456,055,608.20 in the first half of 2021, reflecting a year-over-year increase of approximately 48.9%[157]. Assets and Liabilities - The total assets of the company increased by 14.72% to ¥2,285,954,433.39 from ¥1,992,675,036.08 at the end of the previous year[20]. - The total liabilities increased to ¥713,388,411.42, compared to ¥538,455,623.18 in the previous year, reflecting a growth of 32.5%[144]. - The company's total liabilities reached CNY 818,866,438.48, up from CNY 571,996,007.73 at the beginning of the period[137]. - The company's total equity reached CNY 1,467,087,994.91, up from CNY 1,420,679,028.35 at the beginning of the period[137]. - The company's intangible assets increased by 73.34% to CNY 91,837,104.08, attributed to land use rights acquisition[43]. Production and Operations - The company has established a comprehensive production and sales model centered around herbicides, insecticides, and fungicides, with key products including Fluazifop, Quizalofop, and Chlorpyrifos[27]. - The company’s production capacity for its new products, including Triclopyr and Cyhalofop-butyl, was launched during the reporting period[27]. - The company’s product structure includes fine chemical intermediates, pesticide active ingredients, and formulations, ensuring a stable supply chain for its operations[31]. - The company has been actively managing supply chain challenges due to rising raw material prices and logistics disruptions caused by the pandemic[36]. - The company is enhancing its production processes while ensuring compliance with safety and environmental regulations[36]. Environmental and Regulatory Compliance - The company has received various environmental accolades, including being recognized as a "Jiangsu Province Advanced Environmental Protection Enterprise"[29]. - The company has invested in pollution control facilities, enhancing the efficiency of "three wastes" treatment and reducing emissions[68]. - The company has installed online monitoring equipment for wastewater discharge, ensuring real-time monitoring of COD, total phosphorus, ammonia nitrogen, and total nitrogen[69]. - The company has implemented a comprehensive emergency response plan for environmental incidents, which has been filed with local environmental authorities[71]. - The company continues to optimize production processes and strengthen environmental management to enhance clean production levels[68]. Shareholder and Equity Management - The company did not distribute profits or increase capital reserves during the reporting period[6]. - The company has committed to long-term holding of its shares and may consider reducing its holdings after a two-year lock-up period[83]. - The company will ensure that the share reduction price does not fall below the latest audited net asset value per share[83]. - The company has established a policy to return any illegal gains from share reductions to the issuer[85]. - The company’s major shareholders have pledged to strictly adhere to the profit distribution policy as outlined in the company's articles of association[98]. Research and Development - The company holds 18 authorized invention patents and 2 utility model patents as of June 30, 2022, indicating strong R&D capabilities[34]. - The company is increasing R&D investments to achieve product differentiation and integrate pesticide formulations, active ingredients, and intermediates[56]. - Research and development expenses for the first half of 2022 were ¥21,717,260.83, slightly down from ¥22,047,351.79 in the same period last year[144]. Market and Strategic Initiatives - The company has established partnerships with major multinational corporations, enhancing its market presence and collaboration opportunities[30]. - The company has been focusing on expanding its overseas market, resulting in significant growth in export business[36]. - The company plans to continue its investment in new technologies and product development to enhance competitive advantage[173].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 441,406,976.76, representing a decrease of 2.84% compared to the same period last year[5] - The net profit attributable to shareholders was CNY 30,534,902.58, down 39.39% year-on-year[5] - The net profit after deducting non-recurring gains and losses was CNY 26,563,165.16, a decline of 44.93% compared to the previous year[5] - The basic earnings per share were CNY 0.19, down 38.71% from the same period last year[5] - The weighted average return on equity was 2.13%, a decrease of 1.56 percentage points year-on-year[5] - Total operating revenue for Q1 2022 was CNY 441,406,976.76, a decrease of 2% compared to CNY 454,318,728.70 in Q1 2021[22] - Net profit for Q1 2022 was CNY 30,534,902.58, down 39.4% from CNY 50,375,579.42 in Q1 2021[23] - Earnings per share for Q1 2022 were CNY 0.19, compared to CNY 0.31 in Q1 2021[24] Cash Flow and Assets - The net cash flow from operating activities was negative at CNY -117,559,973.13, a significant decrease of 147.55% year-on-year[5] - The company's cash and cash equivalents decreased to RMB 281,869,129.23 from RMB 364,706,984.85[18] - Cash flow from operating activities showed a net outflow of CNY 117,559,973.13, worsening from a net outflow of CNY 47,489,648.54 in Q1 2021[27] - Cash inflow from investment activities was CNY 198,248,341.42, slightly up from CNY 197,262,676.09 in the previous year[27] - The net cash flow from investment activities was $22,309,734.30, a significant improvement compared to the previous year's negative cash flow of -$193,427,492.25[28] - The ending balance of cash and cash equivalents was $214,427,299.75, down from $323,104,204.94 in the prior year[28] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,088,600,663.62, an increase of 4.81% from the end of the previous year[6] - The total current liabilities increased to RMB 592,119,247.84 from RMB 529,662,101.28[19] - Total liabilities increased to CNY 636,947,805.29, compared to CNY 571,996,007.73 in the previous year, reflecting a growth of 11.3%[20] - The total equity attributable to shareholders rose to CNY 1,451,652,858.33, up from CNY 1,420,679,028.35, marking a 2.2% increase[20] Shareholder Information - The total number of common shareholders at the end of the reporting period was 14,351[12] - The largest shareholder, Yin Fengshan, holds 67,725,478 shares, representing 41.7% of the total shares[12] Operational Changes - The company reported a significant increase in accounts receivable by 98.59%, primarily due to sales with outstanding payment terms[8] - Financial expenses surged by 105.82%, mainly attributed to fluctuations in the USD exchange rate[8] - The company plans to upgrade its production line to increase capacity to 1,700 tons of active ingredients and 1,083 tons of by-products[14] - The company has made strategic adjustments to its fundraising projects, focusing on optimizing production processes and capacity[14] Inventory and Expenses - The company's inventory increased to RMB 393,959,301.20 from RMB 343,560,393.05, indicating a rise in stock levels[18] - Total operating costs increased to CNY 404,894,862.17, up 3.2% from CNY 391,714,150.25 in the same period last year[22] - Research and development expenses for Q1 2022 were CNY 12,316,781.49, an increase of 21.6% from CNY 10,130,613.97 in Q1 2021[23] - The company reported a decrease in sales expenses to CNY 12,249,632.55 from CNY 9,481,025.26 in the previous year, indicating a 29.5% increase[23] Accounting Practices - The company did not apply the new accounting standards starting from 2022, indicating a continuation of previous accounting practices[28]

Financial Performance - The company's operating revenue for 2021 was CNY 1,518,111,081.32, representing a year-on-year increase of 1.61% compared to CNY 1,494,085,529.04 in 2020[22] - The net profit attributable to shareholders for 2021 was CNY 114,725,344.99, a decrease of 51.32% from CNY 235,683,496.73 in 2020[22] - The net profit after deducting non-recurring gains and losses was CNY 99,624,503.09, down 54.57% from CNY 219,296,974.47 in 2020[22] - The cash flow from operating activities for 2021 was CNY 59,758,888.25, a decrease of 62.05% compared to CNY 157,462,098.45 in 2020[22] - Basic earnings per share decreased by 52.00% to CNY 0.72 compared to CNY 1.50 in 2020[24] - Operating profit decreased by 52.36% to CNY 13,377,560.00 from CNY 28,080,210.00 in the previous year[46] - The company reported a net cash flow from operating activities of CNY 5,975,890.00, down 62.05% from CNY 15,746,210.00[46] - The gross profit margin for the main business decreased by 10.51 percentage points, with a gross profit margin of 20.04%[48] Assets and Liabilities - As of the end of 2021, the total assets were CNY 1,992,675,036.08, a slight decrease of 0.22% from CNY 1,996,996,595.29 at the end of 2020[23] - The net assets attributable to shareholders increased by 6.10% to CNY 1,420,679,028.35 from CNY 1,339,038,437.18 at the end of 2020[23] - The company's cash and cash equivalents decreased by 43.39%, from ¥644,221,917.06 to ¥364,706,984.85[64] - The company's investment activities resulted in a net cash outflow of CNY 242,369,164.27, a decline of 430.08% from the previous year[47] Market and Production - The company reported a pesticide production volume of 2,498,000 tons in 2021, indicating a recovery in the industry after a decline from 2016 to 2018[37] - The sales volume of herbicides decreased by 6.19%, while the production volume increased by 10.46%[53] - The domestic market contributed CNY 1,095,401,598.83 in revenue, with a gross profit margin of 20.66%, down 6.03 percentage points year-on-year[51] - The total cost of pesticides for the period reached ¥1,213,520,528.18, an increase of 17.12% compared to ¥1,036,090,245.23 in the same period last year[57] Research and Development - Research and development expenses decreased by 7.50% to CNY 44,129,971.04 from CNY 47,709,545.05[47] - The number of R&D personnel is 167, accounting for 12.31% of the total workforce[61] - The company has established a high-efficiency R&D system centered on customer needs, leading to successful trial production of new products[38] - The company is committed to increasing R&D investment to differentiate its products and enhance competitiveness in the agricultural chemical market[111] Environmental and Sustainability Initiatives - The company is focusing on sustainable development and enhancing safety and environmental standards in its operations[33] - The company has invested in environmental protection facilities, including wastewater biochemical treatment systems with capacities of 2000m³/d, 4000m³/d, and 4800m³/d, to ensure compliance with discharge standards[159] - The company has been recognized as an "Advanced Environmental Protection Enterprise" in Jiangsu Province and a "Friendly Environmental Enterprise" in Yancheng City[166] - The company has established a real-time monitoring system for wastewater discharge, ensuring compliance with chemical oxygen demand (COD), total phosphorus (TP), ammonia nitrogen (NH3-N), and total nitrogen (TN) standards[159] Corporate Governance - The company has established a governance structure consisting of the shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and coordinated operations[115] - The board of directors comprises 9 members, including 3 independent directors, and has established specialized committees to provide scientific and professional opinions for decision-making[117] - The company has implemented a comprehensive investor relations management strategy, enhancing communication with investors and improving governance levels[118] - The company strictly adheres to information disclosure regulations, with the chairman as the primary responsible person for disclosures, ensuring timely and equal access to information for all shareholders[118] Shareholder Information - The total number of shares held by the chairman, Yin Fengshan, increased from 48,375,341 to 67,725,478, a change of 19,350,137 shares due to dividend distribution and transfer[123] - The company has implemented a share repurchase and cancellation strategy, resulting in a reduction of 28,000 shares held by supervisor Wang Li[125] - The company has a clear and transparent cash dividend policy, ensuring compliance with relevant regulations and shareholder interests[149] - The company plans to distribute a cash dividend of 1.77 RMB per 10 shares to all shareholders, based on the total share capital as of the dividend record date[148] Strategic Plans and Future Outlook - The company aims to strengthen its market share in pesticide raw materials while expanding its pesticide formulations and fine chemical intermediates[33] - The company is focusing on investment opportunities in new chemical materials and renewable energy sectors to achieve long-term growth and diversification[108] - The company plans to accelerate the construction of the Sichuan Guang'an base and the production line upgrades for various products, including 1,700 tons of active ingredients and 1,600 tons of intermediates annually[109] - The company provided a forward guidance of 10% revenue growth for the next quarter, projecting revenues of approximately $550 million[130]

2021 年第三季度报告 证券代码：603810 证券简称：丰山集团 江苏丰山集团股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告 期末比上年 | | --- | --- | --- | --- | --- | | | | 期增减变 | 年初至报告期末 | 同期增减变 | | | | 动幅度(%) | | 动幅度(%) | | 营业收入 | 307,606,106.44 | 38.20 | 1,157,419,075.65 | 5. ...